India mRNA Therapeutics Market (2025-2031) | Outlook, Growth, Share, Trends, Size & Revenue, Segmentation, Competitive Landscape, Industry, Forecast, Analysis, Value, Companies

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 India Country Macro Economic Indicators

3.2 India mRNA Therapeutics Market Revenues & Volume, 2021 & 2031F

3.3 India mRNA Therapeutics Market - Industry Life Cycle

3.4 India mRNA Therapeutics Market - Porter's Five Forces

3.5 India mRNA Therapeutics Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 India mRNA Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F

3.7 India mRNA Therapeutics Market Revenues & Volume Share, By End use, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of chronic diseases in India, driving the demand for advanced therapies like mRNA therapeutics.

4.2.2 Growing investment in healthcare infrastructure and research and development in India.

4.2.3 Rising awareness and acceptance of personalized medicine and targeted therapies among healthcare professionals and patients.

4.3 Market Restraints

4.3.1 High cost associated with mRNA therapeutics may limit accessibility to a large portion of the population in India.

4.3.2 Regulatory challenges and approval processes specific to mRNA therapeutics may slow down market growth.

4.3.3 Limited expertise and infrastructure for manufacturing and delivering mRNA therapeutics in India.

6.1 India mRNA Therapeutics Market, By Type

6.1.1 Overview and Analysis

6.1.2 India mRNA Therapeutics Market Revenues & Volume, By Type, 2021- 2031F

6.1.3 India mRNA Therapeutics Market Revenues & Volume, By Prophylactic, 2021- 2031F

6.1.4 India mRNA Therapeutics Market Revenues & Volume, By Therapeutic, 2021- 2031F

6.2 India mRNA Therapeutics Market, By Application

6.2.1 Overview and Analysis

6.2.2 India mRNA Therapeutics Market Revenues & Volume, By Infectious Diseases, 2021- 2031F

6.2.3 India mRNA Therapeutics Market Revenues & Volume, By Oncology, 2021- 2031F

6.2.4 India mRNA Therapeutics Market Revenues & Volume, By Rare Genetic Diseases, 2021- 2031F

6.2.5 India mRNA Therapeutics Market Revenues & Volume, By Respiratory Diseases, 2021- 2031F

6.2.6 India mRNA Therapeutics Market Revenues & Volume, By Others, 2021- 2031F

6.3 India mRNA Therapeutics Market, By End use

6.3.1 Overview and Analysis

6.3.2 India mRNA Therapeutics Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F

6.3.3 India mRNA Therapeutics Market Revenues & Volume, By Research Organizations, 2021- 2031F

6.3.4 India mRNA Therapeutics Market Revenues & Volume, By Others, 2021- 2031F

7.1 India mRNA Therapeutics Market Export to Major Countries

7.2 India mRNA Therapeutics Market Imports from Major Countries

8.1 Number of clinical trials and research studies focused on mRNA therapeutics in India.

8.2 Adoption rate of mRNA therapies by healthcare providers and patients in key Indian regions.

8.3 Investments in mRNA therapeutics research and development by Indian pharmaceutical companies and government organizations.

9.1 India mRNA Therapeutics Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 India mRNA Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F

9.3 India mRNA Therapeutics Market Opportunity Assessment, By End use, 2021 & 2031F

10.1 India mRNA Therapeutics Market Revenue Share, By Companies, 2024

10.2 India mRNA Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters